Gathering Potential and Seeking Future Smart Health I Changzhou Development and Reform Commission went to Jiangsu Baize Cell Biotechnology Co., Ltd. to investigate the construction of key projects

2022-05-25

Recently, Wang Xiaodan, member of the party group and deputy director of Changzhou Development and Reform Commission, led the city and district major offices to the project site of Jiangsu Baize Cell Biotechnology R&D Center in Niutang Town to investigate the project construction and promotion work on the spot. Mayor Tang Feng and Deputy Mayor Zhou Xiaocheng of Niutang Town; Tang Shengjun, General Manager of Jiangsu Baize Cell Biotechnology Co., Ltd., Liu Xinyu, Executive General Manager, and Xia Yan, Assistant General Manager, participated in the investigation.

Wang Xiaodan and his party visited the exhibition hall of Jiangsu Baize, listened to relevant reports on the construction of Jiangsu Baize, and had in-depth exchanges with the person in charge of Jiangsu Baize.

Project Introduction

The Jiangsu Baize Cell Biotechnology R&D Center project is an in-depth cooperation platform jointly funded by Shanghai Cell Therapy Group Co., Ltd. and Jiangsu Jiuzhou Investment Group Co., Ltd. The total investment of the project is 108 million yuan. It is the promoter and practitioner of the "Bai Ze Plan". The cell cryopreservation bank with a total capacity of 300,000 copies is currently the largest immune cell cryopreservation base in the province. It will create a collection of cell cryopreservation. It is a comprehensive base for storage, cell detection, and cell preparation, and is committed to becoming a regional benchmark enterprise in the cell industry.

Company Environment Atlas